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This review focuses on the removal of emerging contaminants (ECs) by biological, chemical 
and hybrid technologies in effluents from wastewater treatment plants (WWTPs). Results 
showed that endocrine disruption chemicals (EDCs) were better removed by membrane 
bioreactor (MBR), activated sludge and aeration processes among different biological 
processes. Surfactants, EDCs and personal care products (PCPs) can be well removed by 
activated sludge process. Pesticides and pharmaceuticals showed good removal efficiencies 
by biological activated carbon. Microalgae treatment processes can remove almost all types 
of ECs to some extent. Other biological processes were found less effective in ECs removal 
from wastewater. Chemical oxidation processes such as ozonation/H2O2, UV photolysis/H2O2 
and photo-Fenton processes can successfully remove up to 100% of pesticides, beta blockers 
and pharmaceuticals, while EDCs can be better removed by ozonation and UV 
photocatalysis. Fenton process was found less effective in the removal of any types of ECs. A 
hybrid system based on ozonation followed by biological activated carbon was found highly 
efficient in the removal of pesticides, beta blockers and pharmaceuticals. A hybrid ozonation-
ultrasound system can remove up to 100% of many pharmaceuticals. Future research 
directions to enhance the removal of ECs have been elaborated.  
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Emerging contaminants (ECs) are primarily synthetic organic chemicals that have been 
recently detected in natural environments [1-3]. ECs are a large and relatively new group of 
unregulated compounds [4] and can potentially cause deleterious effects in aquatic and 
human life at environmentally relevant concentrations which are becoming a growing 
concern [1, 5, 6]. They are the ingredients mostly detected in municipal sewage, daily 
household products, pharmaceutical production plants, wastewater, hospitals, landfills, and 
natural aquatic environment [7-9]. ECs concentration may range from a few ng L-1 to a few 
hundred μg L-1 [8, 10]. Such concentrations in the aquatic environment may cause ecological 
risk such as interference with endocrine system of high organisms, microbiological 
resistance, and accumulation in soil, plants and animals [11], as these ECs are not completely 
removed by conventional wastewater treatments processes [6, 12, 13]. ECs include mostly 
pharmaceutical organic contaminants, personal care products (PCPs), endocrine disrupting 
compounds (EDCs), surfactants, pesticides, flame retardants, and industrial additives among 
others. 
Pharmaceutical organic contaminants and PCPs include analgesics, lipid regulators, 
antibiotics, diuretics, non-steroid anti-inflammatory drugs (NSAIDs), stimulant drug, 
antiseptics, analgesic, beta blockers, antimicrobials, cosmetics, sun screen agents, food 





water quality and potentially affect drinking water supplies, ecosystem and human health [13-
15]. Their environmental bioaccumulation exacerbates the abnormal hormonal control 
causing reproductive impairments, decreased fecundity, increased incidence of breast and 
testosterone cancers, and persistent antibiotic resistance [16]. Of particular concern are 
antibiotic residues which can induce the development of antibiotic resistant genes potentially 
favouring superbugs [6]. 
EDCs are exogenous substances or mixtures that alter the functions of the endocrine 
systems and consequently cause adverse health effect in an intact organism, or its progeny or 
populations [17]. The effects associated with EDCs are breakage of eggs of birds, fishes and 
turtles, problems in reproductive systems, change in immunologic system of marine 
mammals, reduction of sperm of human organ, increase in the incidence of breast, testicle 
and prostate cancers, and endometriosis [14]. Pesticides have immune-depressive effects in 
fishes, mammals and can modify haemopoietic tissue of anterior kidney [18]. Surfactant can 
affect physical stability of human growth hormone formulations and are responsible for the 
endocrine activity [19].  
The potential long-term effects of ECs in water are still uncertain and need further 
investigation. At present, different government and non-government organizations including 
the European Union (EU), the North American Environmental Protection Agency (EPA), the 
World Health Organization (WHO), or the International Program of Chemical Safety (IPCS) 
are considering these problems and setting up directives and legal frameworks to protect and 
improve the quality of freshwater resources [14].  
A variety of different physical, chemical and biological technologies have already 
been used to remove or degrade the residues of ECs over the last few decades [20, 21]. 
Biological treatment technologies are by far the most widely used for ECs removal, including 





anaerobic bioreactor, microalgae bioreactor, fungal bioreactor, trickling filter, rotating 
biological reactor, nitrification, enzyme treatment and biosorption. It has been reported that 
some non-biodegradable organic micropollutants cannot be sufficiently removed using 
biological treatment processes. Chemical treatment technologies are also widely used for the 
degradation of these micropollutants, including conventional oxidation methods such as 
Fenton, ozonation, photolysis and advanced oxidation processes (AOPs) such as ferrate, 
photo-Fenton, photocatalysis, solar driven processes, ultra sound process, and electro-Fenton 
process. Moreover, some hybrid systems have recently been applied to enhance the removal 
of a wide range of ECs. The advantages and challenges of different processes for the removal 
of ECs are outlined in the Table 1. 
The majority of polar and semi polar pesticides and pharmaceuticals will remain 
partitioned in the aqueous phase due to their relatively high water solubility, hence their 
removal by physical processes such as sedimentation and flocculation is not effective [22], 
and has been reported to be less than 10% [23, 24]. Thus further discussions of those 
processes are not reviewed here. The discussion of other physical treatment processes such as 
membrane, reverse osmosis, ultrafiltration, microfiltration, nanofiltration and adsorption 
processes is also excluded from this review, although these physical processes can be part of 
hybrid or integrated treatment technologies for ECs removal.  
Thus, the aim of this review is to critically evaluate the viability of biological, 
chemical, and hybrid treatment processes as a means to remove ECs from wastewater. 
Specifically the article provided a summary of effectiveness of different wastewater treatment 
processes for ECs removal, discussed conventional wastewater treatment processes along 
with advance and hybrid treatment processes for ECs removal, and discussed the challenges 
and the current knowledge gaps limiting the effectiveness of biological and chemical 





2. Biological treatment technologies  
Biological treatment technologies have been widely applied for the removal of ECs 
predominantly by the mechanism of biodegradation. Biodegradation is the process by which 
large molecular weight ECs are degraded by microorganisms such as bacteria, algal and fungi 
into small molecules [4], and even biomineralised to simple inorganic molecules such as 
water and carbon dioxide. In conventional biodegradation process, microorganisms use 
organic compounds as primary substrates for their cell growth and induce enzymes for their 
assimilation [10]. Some ECs are toxic and resistant to microbial growth hence inhibiting 
biodegradation, in which case a growth substrate is needed to maintain microbial growth for 
biodegradation, a process known as cometabolism [10]. Biodegradation methods have 
traditionally been used in wastewater treatment systems for the removal of ECs. They can be 
divided into aerobic and anaerobic processes. Aerobic applications include activated sludge, 
membrane bioreactor, and sequence batch reactor. Anaerobic methods include anaerobic 
sludge reactors, and anaerobic film reactors. The wastewater characteristics play a key role in 
the selection of biological treatments [7, 28]. The wastewater treatment processes can be 
broadly classified as conventional processes and non-conventional processes, which are 
described in subsequent sections. 
2.1. Progress and challenges in conventional treatment processes 
Removal or degradation capacity of ECs depends on the chemical and biological persistence 
of ECs, their physicochemical properties, the technology used, and operation conditions. For 
the highly polar substances e.g. most pharmaceuticals and their corresponding metabolites, 
the most important removal process is through the biological transformation or mineralization 
by microorganisms. The removal rates strongly depend upon the treatment technology, the 
operation conditions, and target contaminants [36]. The identification of degradation products 





concentrations but also they are present in complex matrices that may interfere with detection 
[36, 37]. 
2.1.1. Biological trickling filter and biofilm reactor 
A biological trickling filter is a three-phase system with fixed biofilm carriers. Wastewater 
enters the bioreactor through a distribution zone, trickles downward over the biofilm surface, 
and air moves upward or downward in the third phase [38]. Bio-trickling filters have been 
used in wastewater treatment plants (WWTPs) for decades in the removal of biochemical 
oxygen demand (BOD), chemical oxygen demand (COD), pathogen decontamination, odor 
and air pollution control, but their application to ECs removal has not become wide practice 
[39-41]. Trickling filters or biobeds were used either alone or in combination with other 
treatment processes such as activated sludge. Some bio-processes such as activated sludge, 
aerated lagoon and trickling filters have reported very different removal efficiencies from 
almost complete removal to no removal of some pharmaceuticals from different wastewater 
sources [42]. Kasprzyk-Hordern et al. [43] monitored 55 pharmaceuticals, PCPs, EDCs and 
illicit drugs during wastewater treatment by trickling filter and activated sludge processes 
from South Wales, UK over a period of five months. They concluded that the activated 
sludge treatment was a much more efficient process than trickling filter beds for the removal 
of organic micropollutants. Overall, out of 55 pharmaceuticals and PCPs studied only a few 
were characterised by low removal efficiency (< 50%) during activated sludge treatment. In 
comparison, the WWTP utilising trickling filter beds resulted in, on average, less than 70% 
removal of all 55 PPCPs studied with half of them not being removed, while the WWTP 
utilising activated sludge treatment gave a much higher removal efficiency of over 85% [43, 
44]. Hence there is a need to develop or modify the present bio-trickling process to attain 





In addition, moving bed biofilm reactors were investigated for the removal of 
analgesic pharmaceuticals, with high removal efficiencies being found for ibuprofen (94%), 
naproxen (70-80%) and diclofenac (74-85%) but poor and inconsistent removal being 
observed for clofibric acid (5-28%), ketoprofen (63-73%) and carbamazepine (0-1%) [45]. 
The recalcitrant nature of carbamazepine was the main reason for its almost no observed 
removal. A comparison of removal efficiencies between suspended activated sludge and 
moving bed biofilm reactors, with the use of the Student’s t-test, showed significantly 
different removals in the case of ibuprofen, ketoprofen, carbamazepine and diclofenac [45]. 
As a relatively new technology, the moving bed biofilm reactor has not yet been widely 
explored for EC removal. 
2.1.2. Biological nitrification and denitrification  
Nitrification is the biological oxidation of ammonium to nitrite and nitrate, and denitrification 
is the biological process which is used to reduce nitrate/nitrite to nitrogen gas [10, 46]. 
Denitrification process is carried out at anoxic (i.e. absence of oxygen) conditions [47, 48]. 
Differences in results from recent studies may originate from the variation in operating 
conditions such as hydraulic retention time, sludge retention time, mixed liquor pH and 
temperature. This kind of process is mostly applied together with MBR for wastewater 
treatment. For example, Phan et al. [47] studied ECs removal from wastewater using 
nitrifying and denitrifying condition in MBR (Table S1). The sludge retention time was 25 d 
and nitrification was carried out by autotrophic bacteria under aerobic conditions and 
denitrification process carried out under anoxic conditions. The treatment duration was 
adequate to support proliferation of both heterotrophic and slow growing nitrifying 
microorganisms that supported high organics removal.  
The removal of EDCs such as estrone (E1), 17α-ethinylestradiol (EE2), 17β-estradiol 





benzophenone, galaxolide, oxybenze, salicyclic acid and tonalide) by denitrification has been 
found to be 82-100% at μg L-1 level influent concentration. Pesticides such as atrazine and 
fenoprop showed lower removal efficiencies (8-32%) while triclosan and pentachlorophenol 
were found to be better removed (88-98%) by denitrification process [47]. Pharmaceuticals 
such as ibuprofen, metronidazole and ketofenac were well removed (82-97%) but 
carbamazepine, diclofenac, clofibric acid, gembrozil, erythromycin and roxythromycin were 
less well removed by denitrification process (Table S1). The fate of some EDCs and 
pharmaceuticals by denitrification process was also studied but result was not satisfactory 
[49]. On the other hand, nitrification process was found suitable to remove some ECs such as 
E1, E2 and EE2, galaxolide, tonalide, ibuprofen, naproxen, erythromycin and roxythromycin. 
The removal efficiency during nitrification process followed the order: EDCs > PCPs > 
pharmaceuticals. In case of denitrification process, removal of ECs followed the order of 
EDCs > PCPs > pesticides > pharmaceuticals. In comparison, denitrification process seems to 
be more suitable than nitrification process (denitrification > nitrification) for the removal of 
ECs (Table S1). A challenge in the denitrification and nitrification process is the relatively 
low removal efficiencies for a wide range of ECs, but this process can be merged with MBR 
and other processes to improve its removal efficiencies. 
2.1.3. Biological activated carbon 
The accumulation or artificial immobilization of microorganisms under proper temperature 
and nutrition condition on the surface of activated carbon produces the biological activated 
carbon. In that case activated carbon (mostly granular form) acts as a carrier which can exert 
the adsorption and biodegradation roles simultaneously [50-52]. The mechanism involves the 
interaction of granular activated carbon particles, microorganisms, contaminants and the 
dissolved oxygen in solution [53]. In most cases biological activated carbon process is used 





of a tertiary treatment process for reclamation purpose as it can efficiently remove both 
nitrogen and organic carbon [52]. Such comparative removal efficiencies by filtration, 
ozonation followed by biological activated carbon are listed in Supplementary Table S2, 
where it can be observed that biological activated carbon process can be more effective in the 
removal of ECs (ng L-1 level) especially pesticides (e.g. atrazine and triclosan), beta blockers 
(e.g. atendol) and pharmaceuticals (analgesics, antibiotics, lipid regulator and anti-
depressant) when ozonation process has been carried out first. Biological activated carbon 
process showed lower efficiency in the removal of some EDCs such as E3, bisphenol A, and 
octylphenol but did remove 99% of E1 [50]. Thus biological activated carbon process can be 
very attractive if this process is combined with some oxidation process such as ozonation. 
Therefore for the removal of ECs, it can be concluded that biological activated carbon 
process followed the order of pesticides > beta blockers > pharmaceuticals > EDCs > PCPs. 
As biological activated carbon process was found to be less effective in the removal of EDCs 
and PCPs including some pharmaceuticals, thus this process should mostly be applied in 
hybrid system. Hybrid system was found very impressive in the removal of ECs and 
discussion of such system is covered in section 4.  
2.1.4. Microalgae/Fungi based treatment 
Biologically based wastewater treatment by microorganisms (bacteria, algae and fungi) can 
simulate the ability of natural ecosystems to attenuate pollution from water in a cost effective 
and sustainable way. Microorganism based treatment systems have been proved to effectively 
remove some ECs with the mechanism of degradation and phytoremediation [4, 54, 55]. 
Microorganisms produce some enzymes which are responsible for the biodegradation of the 
ECs. For example, some fungi produce extracellular enzymes with low substrate specificity 
and are very suitable for the degradation of some ECs even at low water solubility [56]. On 





high rate algal ponds has high attention due to the resource recovery of algal biomass, use of 
fertilizer, protein-rich feed or biofuel and high quality effluent. High rate algal pond is 
shallow raceway reactors in which microalgae and bacteria grow in symbiosis. Such system 
is responsible for the degradation of organic matter by heterotrophic bacteria, which consume 
oxygen by micro-algal photosynthesis. Such system does not require aeration [27, 57]. 
Comparative removal of different ECs has been shown in Table 2. Some of the ECs such as 
pharmaceutical beta blockers (atendol, propranolol and sotalol), gastroesophageals and 
anticancer drugs (crimetidine, famotidine ranitidine, acridone and citalopram), anti-
inflamatory drugs (acetaminophen including stimulant butalbital), and antibiotics 
(azithromycin, erythromycin, sulfathazole, sulfapyridine and sulfamethazine) can be removed 
up to 100% by fungal reactors. EDCs such as E1, E2 and EE2 can be removed by more than 
95% at a concentration level of 1 μg L-1 in algae based polishing pond treatment based 
system. Microalgae based treatment system can efficiently remove many types of ECs 
including EDCs, PCPs and pharmaceuticals (analgesic and anti-inflammatory including 
stimulant caffeine) at concentrations of 9-24 μg L-1. But this kind of system has lower affinity 
towards pesticides removal (Table 2). It can be stated that microalgae based treatment system 
has better removal efficiencies of ECs even at high concentration than algae based polishing 
pond. Microalgae based removal of ECs followed the general trend of pharmaceuticals > 
PCPs > EDCs > pesticides. On the other hand, fungi based treatment system followed the 
order of beta blockers > gastroesophageal > anti-inflammatory and stimulants > antibiotics > 
analgesics > lipid regulators > NSAIDs. The comparative data in Table 2 show that 
microalgae based treatment system has better removal efficiencies with high influent 
concentration of ECs. Thus microorganism based treatment processes require further in-depth 





Moreover, in order to improve pesticides removal efficiencies this type of process can be 
integrated with biological activated carbon process.  
2.1.5. Activated sludge process 
Activated sludge is a process where biomass produced in wastewater by the growth of 
microorganisms in aeration tanks takes place in presence of dissolved oxygen [63]. Among 
all conventional wastewater treatment processes, the activated sludge process is the most 
widely used and applied in so many ECs removal around the world, and as the proportion of 
removal by primary setting, chemical precipitation, aerating volatilization and sludge 
absorption is small, the majority of ECs in wastewater is removed by biodegradation [64-66]. 
This process utilizes bacteria and protozoa for treating sewage and industrial wastewaters by 
the utilization of air and a biological floc. These kinds of microorganisms can break down the 
organic matter into carbon dioxide, water and other inorganic compounds. It has lower capital 
cost than advance oxidation processes and generally more environmentally friendly than 
chlorination process [13, 29]. Figure 1 shows the removal of 102 target ECs including 23 
EDCs, 3 pesticides, 4 beta blockers, 11 PCPs, 10 surfactants, and pharmaceuticals by 
activated sludge processes [13, 63, 64, 67-73]. All the data for activated sludge based 
treatment systems are listed in Appendix Table S3. Ten types of surfactants have been 
successfully removed (95-98%) by the activated sludge processes at a concentration of 
several mg L-1. Higher removal efficiencies of surfactants by activated sludge may be due to 
their sorption susceptibility toward microorganisms and also degradation nature of the 
contaminants (Figure 1b) [63]. Activated sludge process is also very effective in the removal 
of EDCs in the range of 75-100% (Figure 1a). Some EDCs such as androstenedione, 
androsterone, EE2, coumestrol, E3, E1, 2 hydroxy estrone (2-OH E1), alpha hydroxyl estrone 
(α-OH E1), progesterone, testosterone, bisphenol A and octylphenol have highest estrogenic 





relative binding, biotransformation and affinity. Thus microorganisms can easily accumulate 
and degrade such compounds into simpler substances [64, 74]. Environmental condition such 
as dissolved oxygen is a vital factor for the removal of EDCs and their removal efficiency is 
higher in aerobic conditions than in anaerobic conditions [75]. Activated sludge is also 
suitable for the removal of many PCPs at 78-90% although cashmeran, celestolide and 2,4-D 
are less well degraded (around 60%) due to both sorption and biodegradation [63]. The 
removal of polar herbicides (atrazine, diuron, and triclosan) and beta blockers (metrolol, 
atenolol, metoprolol) was found to be poor during activated sludge treatment (Figure 1a), 
which was due to adsorption onto suspended solids rather than biodegradation [63]. Activated 
sludge process based treatment plant with lower retention time has a limited capacity to 
remove highly polar pharmaceuticals, since most of such compounds cannot be metabolized 
by microorganisms as a source of carbon and may even inhibit the activity of the 
microorganisms [15, 63, 76]. But some pharmaceuticals such as stimulant drugs (caffeine, 
nicotine and paraxanthine) and some metabolites (carbamazepine 10-OH, carbamazepine 2-
OH, carbamazepine 3-OH, and carbamazepine–DiOH) were found to be well removed (95-
99.9%) from wastewater due to their sorption onto the suspended solids (Figure 1b). 
Pharmaceuticals such analgesic ECs can be removed up to 65 to 100%. The removal of 
pharmaceutical ECs by activated sludge system followed the general order of stimulant drugs 
> metabolites > analgesics > antibiotics > anti-inflammatory > lipid regulator > NSAIDs > 
other pharmaceuticals (fluoxetine, iopromide, omeprazole, ranitidine and tamoxifen). Overall 
trend for ECs removal by activated sludge process can be written as surfactants > EDCs > 
PCPs > pesticides > pharmaceuticals > beta blockers. Finally, current knowledge about the 
degradation mechanism in activated sludge is not complete and activated sludge can generate 





which should be carefully addressed. The activated sludge process can also be integrated with 
ozonation or MBR in order to improve the removal efficiencies of ECs.                                                                                                                                                                                                                                                                                                                                                                   
2.1.6. Aerobic, anaerobic and facultative microbiological treatment 
During wastewater treatment many ECs are sorbed (if not degraded) to some extent on 
suspended solids and as a result they are found in sludge through sedimentation occurring in 
primary and secondary clarifiers [77]. Aerobic, anaerobic and facultative bioreactor based 
biological treatment process is used for the stabilization of excess sludge derived from 
activated sludge [78-80]. The main mechanism involves bacteria present in the activated 
sludge consuming ECs and converting them into carbon dioxide. Anaerobic digestion is one 
of the most widely used processes for sludge stabilization where treated sludge is often 
discharged on the soil or reused for agricultural purposes, and the fate of ECs is mainly 
governed by ECs molecular properties such as the presence of electron accepting or donating 
functional groups [81]. If the sludge containing ECs is directly used in agricultural then it 
may be a threat for the environment and human health [82, 83]. Degradation of ECs may be 
influenced by the sludge retention time and temperature. Some other factors such as 
microbial population, target compounds bioavailability and co-metabolic phenomena can 
affect the biodegradation of some ECs [84]. Degradation by aerobic, anaerobic and 
facultative digesters, ponds, lagoons or bioreactors of different categories of ECs is 
represented in Table S4 [84-86], which shows that anaerobic process for ECs degradation has 
been mostly studied in EDCs removal from activated sludge. The removal efficiencies ranged 
from 60 to 100% with high concentrations of ECs [87]. Some of EDCs such as E2, EE2, 
bisphenol A and nonylphenol have been found to show high removal efficiencies by aerobic 
biodegradation process. Pharmaceuticals have been well been removed (65-100%) by the 
treatment in aerobic lagoons due to the increase in hydraulic retention time [63, 85]. PCPs 





removal efficiencies were not satisfactory due to slow degradation nature of these ECs. 
However, it can be observed from Table S4 that pharmaceuticals can be more effectively 
removed by aerobic than anaerobic biodegradation process, while EDCs can be slightly more 
effectively removed by anaerobic than by aerobic processes. In summary, ECs removal 
followed the trend of aerobic > anaerobic > facultative process. These kinds of processes 
need long hydraulic and sludge retention time to ensure a satisfactory removal of ECs. 
To summarise, conventional treatment systems such as activated sludge, biological 
activated carbon and microalgae systems can successfully be applied to some extent for 
specific class of ECs removal. More effective and specific treatment is required to reduce the 
environmental and potential impact of the effluents. Thus these processes can be coupled 
with other chemical and physical treatment processes such as ozonation, ultrasound, 
ultrafiltration, and photo-Fenton processes. In addition, there is a need to increase our 
knowledge about the fate of ECs during wastewater treatment for the implementation of 
better removal technologies. Future work on WWTP should demonstrate to what extent ECs 
can be removed from wastewater and to what extent the implementation of an improved 
technology is feasible, taking into account other micropollutants as well as the broad variety 
of complex matrices. 
 
2.2. Progress and challenges in non-conventional treatment processes  
2.2.1. Biosorption 
Biosorption is a biologically based treatment process functioning with a different mechanism 
than biodegrading process. In biosorption, microorganisms are immobilized onto an 
adsorbent and thus sorption and bio-oxidation occur [88]. After that pollutants can passively 
concentrate and bind onto certain biomass cellular structure. Nguyen et al. [89] compared the 





cultured and harvested white rot fungus (T. versicolour) and that inactivated by sodium azide. 
Biosorption based removal of some ECs is shown in Table 3. The removal of ECs such as 
17β-estradiol-17α-acetate, pentachlorophenol, 4-tert-octylphenol and triclosan was achieved 
by more than 80% as their octanol water partitioning coefficient (Kow) is high. Some 
pharmaceuticals such as ibuprofen, naprox, and gemifibrozil were found to achieve 100% 
removal efficiency by using live white rot fungi. It is clearly seen that often live white rot 
fungi based treatment of ECs had higher efficiency than inactivated white rot fungus based 
treatment (biosorption). Biosorption of ECs such as EE2, bisphenol A and benzophenone has 
also been studied by Banihashemi and Droste [92] who indicated that the soluble 
concentration decreased rapidly for selected micro-constituents (triclosan > EE2 > bisphenol 
A) and the soluble and solid phase concentrations continued to decrease slowly during the 
length of the experiment which indicates the possible biodegradation of these compound in 
both phases. The removal of estrogens can occur by a combination of biosorption and 
biodegradation interactions due to their high Kow values and low biodegradable nature with 
low Henry’s Law constant [98].  
2.2.2. Membrane bioreactor 
Recently, MBR is widely viewed as being a state-of-the-art technology for municipal and 
industrial wastewater treatment due to its high effluent quality achieved with respect to many 
ECs [99-102]. MBR is able to effectively remove a wide range of ECs including compounds 
that are resistant to activate sludge process and constructed wetland [13, 24, 103]. This can be 
achieved due to sludge retention on the membrane surface which can promote microbial 
degradation and physical retention of all molecules larger than the molecular weight of the 
membrane. The removal of ECs in MBR system can be affected by sludge age, concentration, 
and existence of anoxic and anaerobic compartments, composition of wastewater, operating 





MBR process. Adsorption and biodegradation were found to be responsible for the removal 
of ECs by MBR treatment. Adsorption mechanism will be dominating when the log Kow is 
greater than 3.2. Highly hydrophobic compounds (log Kow > 3.2) did not accumulate in the 
membrane and some compounds with a moderate hydrophobicity accumulate significantly in 
the solid phase. The results provide a framework to predict the removal and fate of some ECs 
by MBR treatment [104]. Table 3 shows the removal efficiency of EDCs, pesticides, beta 
blockers, PCPs and antiplatelet agents by MBR technology, which is high for 15 target EDCs 
varying from 92 to 99% at relatively high concentrations (1-5 μg L-1). In comparison to 
conventional activated sludge process, MBR can remove higher amount of EDCs from 
wastewater [89-93, 105]. PCPs such as salicylic acid and propyl parabene were removed by 
around 100% in MBR system. The removal of pesticides such as atrazine, dicamba, fenoprop, 
2,4-D and pentachlorophenol from wastewater by MBR was not satisfactory except for 
triclosan removal which can be up to 99%. Some ECs such as beta blockers can be removed 
by this process at 70-80% and atendol can be removed by up to 97%. In the case of 
pharmaceuticals removal, MBR showed a mixed performance. Some pharmaceuticals can be 
well removed whilst other pharmaceuticals were found to be poorly degraded in MBR [5, 91-
93, 105]. For example, antibiotics (azithromycin, clarithromycin, erythromycin, ofloxacin 
and sulfamethaxazole), analgesics (carbamazepine, citalopram, ibuprofen, lorazepan, 
metronidazole, preimidone and trazodone), anti-inflammatory drug (acetaminophen) and 
stimulant (caffeine) were found to be removed by MBR at 75-95%. The removal of other 
pharmaceuticals was not satisfactory, although the removal rate of some of them was higher 
than biosorption and algal based polishing ponds treatment processes (Table 3). In general, 
the removal of some slowly degradable pharmaceuticals such as antibiotics and analgesics in 
MBRs is better due to the relatively long sludge ages, which leads to the development of 





removal of pharmaceuticals such as anti-inflammatory and stimulant drugs by MBR and 
activated sludge is comparable. In summary, from the literature results it could not be 
concluded that pharmaceutical removal in MBR reactors is better as many other factors have 
been indicated that may affect biodegradation rates, which are not directly related to the 
reactor configuration [106].  For the removal of pharmaceuticals in MBR (as listed in Table 
3), their efficiency followed the order of analgesics > antibiotics > anti-inflammatory and 
stimulants > others pharmaceuticals. The overall trend of ECs removal by MBR can be 
written as EDCs > PCPs > beta blockers > pharmaceuticals > pesticides. The efficiencies of 
diverse microbial populations in the elimination of selected ECs (especially pesticides and 
pharmaceuticals) and the optimization of design and operating parameters are needed to 
provide focus for further research in this area. Other factors such as membrane fouling, 
clogging, operational failures are still costly compared to constructed wetland and other 
established technologies [31, 63]. Moreover, scale-up from pilot plant to industry-scale MBR 
should also be investigated to assess if the processes and ECs elimination can be extrapolated 
to commercial scale operations.  
2.2.3. Constructed wetland 
Constructed wetland is a biologically based wastewater treatment engineered system that is 
designed and constructed to reproduce the processes occurring in natural wetland within a 
more controlled environment. Constructed wetland based wastewater treatment is achieved 
through an integrated combination of biological (biodegradation), physicochemical (sorption) 
and chemical (oxidation) interactions among plants, substrate and soil [30]. Soil acts as the 
main supporting material for plant growth and microbial films. Moreover, the soil matrix has 
a decisive influence on the hydraulic processes. Both chemical soil composition and physical 
parameters such as grain-size distributions, interstitial pore spaces, effective grain sizes, 





the biological treatment systems [9]. Constructed wetland is classified as subsurface/surface 
flow (SFCW), horizontal flow (HFCW) and vertical flow (VFCW) systems according to their 
wastewater flow regime [107]. Moreover, constructed wetland can be combined to form 
hybrid systems to take advantage of the characteristics of each different system [4]. ECs 
removal efficiencies by different constructed wetland are shown in Table 4.  EDCs such as 
E1, E2, EE2, steroid estrogens, bisphenol A and phthalates can be successfully removed by 
75-100% [30, 108]. 
SFCW has been found effective for the removal of pesticides, beta blockers such as 
mecoprop, MCPA, terbuthylazine and triclosan at 80-100%. In the removal of PCPs all the 
constructed wetland processes showed good performance, and PCPs removal followed the 
general order of HFCW > VFCW > SFCW (Table 4). Constructed wetland also showed a 
good removal capacity for pharmaceuticals. For example, pharmaceutical analgesics and 
antibiotics can be effectively removed by different constructed wetland with high removal 
efficiencies. Some analgesics such as diclofenac, ibuprofen, and naproxen can be removed by 
up to 100%. Full scale surface flow constructed wetland has pronounced effect in the removal 
of analgesics from wastewater [109]. The general trend for analgesics followed the order of 
SFCW > HFCW > VFCW. On the other hand, HFCW was found to be better than SFCW for 
the removal of antibiotics from wastewater. Overall removal efficiencies based on the 
effluent quality by constructed wetland can be written as EDCs (constructed wetland) > 
pesticides (SFCW) > PCPs (HFCW > VFCW > SFCW) > pharmaceuticals (HFCW > SFCW 
> VFCW). Constructed wetland technology can be successfully applied for small 
communities for the remediation of a wide range of ECs but it will be difficult to use it in 
large cities due to the lack of space to perform such wastewater treatment processes [110]. 





costs of other technologies such as MBR, ultrafiltration and oxidation processes, or the 
removal efficiency was not satisfactory for a wide range of ECs using existing technologies. 
Biological treatment processes can be applied to remove a wide range of ECs from 
wastewater. The comparison of different conventional and non-conventional biological 
treatment processes is carried out in terms of their average removal efficiencies, and this 
relationship is represented in Figure 2. EDCs can be well removed by MBR and activated 
sludge processes, and treatment efficiency follows the order: MBR > activated sludge > 
aerobic > constructed wetland > microalgae > biological activated carbon > anaerobic 
process. A wide range of EDCs can be removed by activated sludge process. Pesticides can 
be efficiently removed by biological activated carbon technology, with the average removal 
efficiencies by different biological processes decreasing as biological activated carbon > 
microalgae > constructed wetland > MBR > activated sludge. Beta blockers can be best 
removed by MBR process, followed by aerobic process and finally activated sludge process 
(Figure 2). The application of other biological processes in the removal of beta blockers was 
not studied sufficiently. Average removal efficiencies of different PCPs were found to be 
better removed by MBR processes. Based on the average removal efficiencies by biological 
treatment processes, PCPs followed the trend of MBR > microalgae > constructed wetland > 
activated sludge > biological activated carbon > anaerobic process. Surfactant based ECs can 
be well removed by activated sludge process. Surfactants removal by other biological 
processes has not been studied extensively. On the removal of analgesic pharmaceuticals, 
biological activated carbon and aerobic processes were found to be more efficient than 
activated sludge process. The average removal efficiencies of analgesic ECs by different 
biological processes can be written as aerobic > biological activated carbon > microalgae > 
constructed wetland > MBR > anaerobic > activated sludge. Some of the pharmaceutical lipid 





Average removal efficiency of antibiotics was found to be higher than by biological activated 
carbon process. The general trend of different antibiotics removal followed the order of 
biological activated carbon > aerobic > MBR > anaerobic > constructed wetland > activated 
sludge. Finally, some of miscellaneous pharmaceuticals can be better removed by microalgae 
process, as represented in Figure 2. 
 
3. Chemical treatment technologies 
Biological wastewater treatment technologies can be effective in removing many class of ECs 
depending on the target compounds, type of wastewater, and operation conditions. For 
example, polar pharmaceuticals and beta blockers showed variable removal efficiencies in 
different biological processes. Therefore, chemical treatment technologies should be explored 
as alternatives with the intention of finding suitable polishing techniques to further remove 
ECs. These technologies are broadly defined as aqueous phase oxidation methods based on 
the intermediary of highly reactive chemical species [124]. Oxidation reactions have 
primarily been used to supplement rather than replace conventional systems and to enhance 
the treatment of ECs [125]. Chemical agents such as chlorine, hydrogen peroxide, ozone as 
well as the combination of these oxidants including transition metals and metal oxides based 
catalysts in the so-called advanced oxidation processes (AOPs) are required for chemical 
oxidation of ECs from wastewater. In addition, an energy source such as ultraviolet-visible 
radiation, electric current, solar, gamma-radiation and ultrasound are also used [126]. In 
AOPs, the oxidations of ECs are based on the production of free radicals, in particular the 
hydroxyl radicals that facilitate the conversion of pollutants to less harmful and more 
biodegradable compounds [126, 127]. The ultimate aim of chemical oxidation is the 
mineralisation of pollutants, with their conversion to carbon dioxide, water, nitrogen and 





solution are usually in the order of 106-109 M-1 s-1 [33]. Chemical oxidation processes may 
change pharmaceuticals’ polarity and the number of functional groups which in turn affect 
their functionality in the organisms. All the data for chemical based treatment systems have 
been listed in Supplementary Table S5. Some of the oxidation based chemical treatments of 
ECs have been described in the subsections 3.1 and 3.2.  
3.1. Progress and challenges in conventional oxidation processes 
3.1.1. Chlorination  
Most of chemical oxidation processes have demonstrated high effectiveness in the 
degradation of ECs present in wastewater system which are oxidized to readily biodegradable 
and less toxic compounds. Sometime less reactive species such as chlorine (gaseous chlorine 
and hypochlorite) and bromine have also been used in wastewater treatment. The effect of 
chlorine on the removal of some ECs has been carried out by Noutsopoulos et al. [128] using 
1000 ng L-1 of each ECs pollutant after exposing initial chlorine dose of 11 mg L-1 for 60 min. 
The maximum removal efficiencies were 95% and 100%, respectively for naproxen and 
diclofenac. The removal of EE2 by chlorination was found to be up to 100% within 10 min 
[129]. The removal efficiencies of other ECs such as nonylphenol, nonylphenol 
monoethoxylate, nonylphenol diethoxylate, bisphenol A, triclosan, ibuprofen and ketoprofen 
ranged from 34% to 83%. The removal of some ECs may be enhanced using increased 
chlorine dose, extended contact time or changing pH [130]. Moreover, it was observed that 
the reaction rate of chlorination process was three orders of magnitude lower than that of 
ozonation process during the removal of ECs such as amitriptyline hydrochloride, methyl 
salicylate and 2–phenoxyethanol [131]. In addition, chlorine and chlorine dioxide are potent 
oxidants which may produce some sub-products during wastewater treatment and the degree 






Ozone is a very powerful oxidant that reacts selectively with double bonds and aromatic rings 
of ECs with a high electron density [132]. Ozonation is also an AOP which involves direct 
reaction of ECs with ozone molecules through the action of secondary oxidants such as 
hydroxyl radicals produced from ozone in aqueous solution [15, 133], which increase the 
oxidation capacity. Ozonation has been implemented as the principal treatment method or to 
enhance the biodegradability and efficiency of subsequent treatment. Ozone production is an 
energy intensive process, therefore making it costly to implement. An ozone treatment system 
may increase the energy demand over a conventional WWTP by 40-50%. The use of ozone 
as a means of breaking down pharmaceuticals in wastewater has been the subject of 
numerous studies over the last decade [7]. Ozonation has shown a broad range of effective 
removal of ECs and in general, this process can remove all types of ECs by 90-100% (Figure 
3). From Figure 3a, it can be seen that ozonation process has pronounced effect in the 
degradation of EDCs such as E1, E3, E2, EE2, bisphenol A and nonylphenol at a high 
concentration level (up to 50 μg L-1) with 100% removal efficiencies except for E1 (90%). 
This may be due to the high Kow and high susceptibility of EDCs toward degradation by 
ozonation [14, 133]. A degradation of 95-100% of pesticides including alachlor, atrazine, 
chlorfenyvinphos, diuron and isobroturum rapidly occurred at even higher concentration level 
(up to 18 mg L-1). But 2,4-D and diazinon have shown less tendency toward ozonation 
oxidation process [134]. Many pharmaceuticals were found to be effectively removed by 
ozonation except perindopril, phenytoin, sertraline and ketoprofen (Figure 3b) [14, 135, 
136].  
Figure 4a shows the removal efficiencies of ECs by ozonation in the presence of 
hydrogen peroxide. Pesticides, pharmaceuticals and beta blockers were very successfully 





relevant concentrations [14, 133]. The problem with ozonation is the high energy 
consumption, formation of some oxidative by-products and interference of radical scavenger 
[13, 25]. Thus these are the areas which need to be considered for future ozonation research. 
3.1.3. Fenton process 
Fenton is an oxidation process that involves reactions of hydrogen peroxide in the presence of 
iron to produce hydroxyl radicals [137]. Since iron is abundant and non-toxic, Fenton 
reactions are a viable option for wastewater treatment. Oxidation power of H2O2 is enhanced 
by its oxidation to OH˙ and the chain reactions of Fenton chemistry can be represented as: 
Fe2+ + H2O2  Fe3+ OH˙ + OH-    (1) 
Fe3+ + H2O2  Fe2+ + HO2˙ + H+   (2) 
Ferrous ion can be regenerated from Fe(III) through above reaction [138]. But 
reaction 2 is much slower than reaction 1. As a result, Fe(III) accumulates in the solution and 
then precipitates as Fe(OH)3 sludge [138]. Thus the removal of Fe from solution can decrease 
the process efficiency. Moreover, it requires a significant amount of reagents that increases 
the operational costs. Another drawback of classical Fenton process is the unintended 
consumption of formed OH˙ by hydrogen peroxide and ferrous ions through the following 
reactions: 
OH˙+ Fe2+  Fe3+ + OH-    (4) 
OH˙ + H2O2  H2O + HO2˙    (5) 
At high reagent concentrations, these reactions can strongly hinder the efficiency of 
the process since HO2˙ formed is a weak oxidant compared to OH˙. For the remediation of 
ECs in wastewater the iron concentrations used, normally added as ferrous sulphate, are 
commonly in the range of 10–50 mg L-1. As hydrogen peroxide is consumed in the reaction, 
the added amount of this reagent is strongly dependent on the amount of organic matter and 





using only Fenton process. By applying only Fenton process the removal of ECs was not 
satisfactory compared to other oxidation processes such as photo-Fenton and ozonation 
(Figure S1a). Thus it requires the addition of other compounds such as hydrogen peroxide, or 
using a catalyst, solar or any other light source to promote the ECs removal from wastewater. 
3.1.4. Photolysis 
Photolysis is a process in which molecules of ECs undergo decomposition as a result of the 
absorption of light or radiations [139]. Though different sources of light are utilised, 
disinfection of water using UV remains as a commonly used technique. There are two types 
of photolysis, namely direct photolysis where the direct absorption of photons lead to 
degradation of pollutants and indirect photolysis which occurs in the presence of 
photosensitisers such as using of hydrogen peroxide or other photosensitisers. Figures 4 and 
S1 show the UV photolytic removal of some ECs in the absence (Figure S1b) and presence 
of hydrogen peroxide (Figure 4b), respectively. Figure S1b shows that photolytic process 
has high efficiency in the removal of EDCs (5-10 μg L-1) and pesticides from 80% to 100% 
[64, 91]. Some pharmaceuticals such as diclofenac, iopamidol, ketoprofen, mefanamic acid, 
oxytetracycline and tetracycline can be completely removed. On the other hand, UV 
photolysis process was found to be less effective in the removal of beta blockers. In general, 
UV photolysis process followed the order of beta blockers < other pharmaceuticals < 
analgesics pharmaceuticals < antibiotics < pesticides < EDCs. 
 In addition, UV photolysis in the presence of hydrogen peroxide has much more 
pronounced effect on the removal of ECs as represented in Figure 4b. In terms of removal 
efficiencies, UV photolysis in the presence of hydrogen peroxide has been found better than 
only UV photolysis. UV photolysis/H2O2 process can remove most of ECs successfully by up 
to 100% with the exception of some ECs such as lincomycin and diclofenac (around 80%), 





effective than UV photolysis/H2O2 for the removal of all ECs except EDCs where they 
followed the order of UV photolysis > UV photolysis/H2O2.  
 Moreover, gamma radiations have also successfully been applied in the removal of 
ECs from wastewater. Data for the removal of some pharmaceuticals are represented in 
Table 5, which show that gamma radiation based oxidation process can successfully remove 
100% of ECs such as metoprolol, carbazepine, diclofenac, ketoprofen, mefenamic acid, 
clofibric acid, cefaclor, and chloramphenicol at mg L-1 concentration level [140-144]. Other 
ECs showed removal efficiencies in a range of 80-95% except sulfamethoxazole (53%). The 
maintenance and production cost of gamma radiation can be a burden in order to obtain a cost 
effective removal of ECs. Therefore this kind of process is still at early stage and requires 
more research. 
 
3.2. Progress and challenges in advanced oxidation processes  
3.2.1. Ferrate 
Ferrate (FeO4
2-) is an excellent oxidizing agent which has a powerful disinfection action. It 
can generate a Fe(OH)3 type gel which precipitates and removes other ions. Over the last 
decade, the high oxidation state of ferrate was of interest due to its environmental, industrial 
and biological importance. Ferrate can be used for the removal of arsenic and ECs such as 
estrogens, pharmaceuticals and PCPs [145]. The main mechanism involved in ECs treatment 
is oxidation/disinfection by Fe6+ and coagulation/flocculation by Fe3+. Several ECs such as 
E1, E2, EE2, bisphenol A, 4-tert-octylphenol and sulfamethoxazole were degraded at a rate 
of 6400 to 7700 M-1 s-1 at pH 7 [146]. Ferrate can oxidize some organic micropollutants by 
up to 90% at ng L-1 level concentrations. Ferrate has been observed to be superior in 
disinfecting coliforms in WWTPs and sewage sludge. However the main problems with 





Moreover, there have been limited applications in using ferrate for ECs removal. Overall, 
there has been no adverse effects from ferrate which should thus be further explored for ECs 
removal with good potential [147]. 
3.2.2. Electro-Fenton processes 
Electro-Fenton process has recently been developed to overcome the drawbacks of the 
classical Fenton process and to increase the efficiency of pollutant removal [138]. In this 
process, H2O2 is electrochemically generated in situ in a controlled way [148]: 
O2 + 2H
+ + 2e-  H2O2    (6) 
Another electrochemical process named photoelectron–Fenton process is also used, in 
which the conditions remain the same as electro–Fenton process but it is simultaneously 
irradiated with UVA light. Thus UVA light accelerates the degradation rate of contaminants 
in the reaction phase and increases the regeneration rate of Fe2+. Moreover, OH˙ can also be 
produced from the following reactions [138]: 
[Fe(OH)]2+ + hv  Fe2+ + OH˙  (7) 
Fe(OOCR)2+ + hv  Fe2+ + CO2 + R˙  (8) 
Electro-Fenton processes appear to be environmentally friendly and efficient with in 
situ generation of the Fenton’s thereby avoiding (i) the cost of reagents and risks related to 
their transport and storage, (ii) the formation of sludge, and (iii) side reactions due to 
maintenance of small reagent concentrations in the medium [149]. Electrochemical Fenton 
processes can be enhanced by the additional application of UV radiation or ultrasound. Solar 
radiation can also be used (solar photoelectro-Fenton process). But problem is that additional 
energy is required for photo or sound assistance and their installation and operational costs 
are involved in comparison to classical electrochemical AOPs except solar photoelectron-
Fenton process [146]. Some of the ECs removal by electro-Fenton, electro photo-Fenton and 





treatment can oxidize ECs at higher concentration (mg L-1 or g L-1) than relevant to the 
environmental levels. Some pesticides such as atendol, metoprolol, propranolol, triclosan and 
triclocarban and some antibiotics such as cephalexin, sulfamthazine, sulfamethaxazole, 
tetracycline and acetaminophen were found to show enhanced removal capacity by electro-
Fenton process [149, 150]. Solar photoelectro-Fenton process has also been applied for the 
removal of beta blockers such as atendol, metoprolol tartrate, propranolol hydrochloride, with 
88-93% efficiency [151]. Thus electro-Fenton process seems to be better than solar 
photoelectro-Fenton process. 
The most important advantage of these processes is that they can degrade 
pharmaceuticals of higher concentrations very effectively than by some conventional 
processes. The problem with such kinds of AOPs based treatment is that the maintenance and 
operation cost is high. Conventional treatment processes such as activated sludge, constructed 
wetland, microorganism based algal treatment and biosorption based treatment are more cost 
effective but cannot maintain their performance when influent contaminant concentration is 
high.  
3.2.3. Photo-Fenton process 
Photo-Fenton reactions are widely used AOPs for the removal of ECs in wastewater. These 
processes involve the use of UV light to produce radicals by reactions of hydrogen peroxide 
in the presence of iron. Photo-Fenton reactions are also possible in sunlight avoiding the use 
of UV light. Photo-Fenton studies are usually developed in acidic or near neutral conditions 
which are optimum for aquatic solutions not containing organic matter. In acidic solutions, 
Fe3+ forms the hydroxyl complexes such as Fe(OH)2+ and Fe(OH)2
4+, which absorb light in 
the UV/visible region, undergoing photoreduction to generate OH˙ and Fe2+ (reaction 7). 
Thus the whole mechanism is enhanced as more OH˙ are being produced and Fe2+ can be 





neutral, the ferric ions precipitate to form amorphous ferric oxyhydroxides, in the absence of 
other ion complex substances. Thus Fe2+ can react with hydrogen peroxide to produce OH˙, 
and the oxidized ligand can be involved in new reactions for the micropollutants degradation 
[2]. Therefore, the effluent should be acidified to reach this value and then neutralization is 
required before discharge. However, important efforts are being devoted to develop photo-
Fenton processes under milder conditions. Oxidation of different ECs by photo-Fenton 
process is represented in Figure 5a. In general, many types of pharmaceuticals have been 
found to show higher removal efficiencies (95-100%) by photo–Fenton process except 
penicillin G [2, 12, 16, 137]. Six anti-inflammatory pharmaceuticals such as antipyrine, 4AA, 
4AAA, 4FAA, 4MAA and metronidazole have been successful degraded by this process with 
higher removal efficiencies than by other processes. However photo-Fenton was found to be 
less effective in the removal of EDCs with relatively high Kow values. Pesticides including 
atrazine, diuron, mecoprop and terbutrynwere were found to be better oxidized by photo-
Fenton process with the exception of triclosan and abamectin (Figure 5a).  
 Alternatively, solar photo-Fenton process was also applied in the removal of ECs by 
up to 90% at a contaminant concentration of 5 μg L-1 (Table 5) [9]. Thus it can be concluded 
that UV based photo–Fenton process can remove higher amount of pharmaceuticals and beta 
blockers than solar photo–Fenton based process: UV photo-Fenton > solar photo-Fenton. 
3.2.4. Photocatalysis 
Photocatalysis is the transformation of chemicals by a catalyst that is activated in the 
presence of light that provides adequate energy [152, 153]. Most photocatalysts are 
semiconductor metal oxides which characteristically possess a narrow energy band gap. 
Photocatalysis is used to overcome the disadvantages of photolysis, especially the slow rate 
of degradation. The catalyst takes part in the reaction, increases the rate of reaction but 





heterogeneous photocatalysts due to its cost effectiveness, inert nature and photo stability 
[155]. In addition, ZnO has been reported to catalyse the photo-oxidation of pharmaceuticals 
such as carbamazepine and antibiotic tetracycline. In fact, fast removal of tetracycline was 
observed with ZnO under optimized conditions (basic pH), although the major drawback of 
this material is that it suffers from corrosion at low pH values. The removal efficiencies of 
ECs by photocatalysis are presented in Figure 5. EDCs such as E1, E2, EE2, E3, bisphenol A 
and progesterone can be highly degraded by up to 100% and the removal efficiencies are 
higher than by photo-Fenton based AOPs (Figure 5b). High degradation rate of 
pharmaceuticals such as analgesics can be easily achieved using photocatalysis process. The 
removal of ECs by photocatalytic process generally followed the order of EDCs > analgesics 
pharmaceuticals > pesticides > other pharmaceuticals. For the removal of pesticides such as 
aldrin, diazinon, malathion and some antibiotics such as amoxicillin, ampicillin and 
chloxacclin, an alternative process such as photocatalysis in the presence of hydrogen 
peroxide can also be applied with excellent removal efficiencies (99-100%) [156, 157].  
3.2.5. Solar photocatalysis  
Solar photocatalytic process is an emerging and promising technology both as an alternative 
treatment to conventional wastewater treatment methods and enhancement of 
biodegradability of highly toxic and recalcitrant pollutants [167]. A promising alternative to 
semiconductor-based solar photocatalysis of some pharmaceuticals can also be applied. Data 
in Table 5 show that many ECs can be removed by up to 85% by solar photocatalysis process 
[129, 155]. The removal of analgesic pharmaceuticals is better achieved by UV photo-Fenton 
process.  
3.2.6.  Miscellaneous processes 
Besides AOP based processes some other technologies have also been applied for the 





irradiation (also called sonochemical irradiation) and titanium based ultrasound irradiation. 
EDCs such as E1, E2, E3 and equilin were found to be removed by up to 80-90% from 
aqueous solution by ultrasound processes at a concentration of 10 μg L-1 [65, 172]. Naddeo et 
al. [173] investigated sonochemical degradation of 23 ECs (such as acetaminophen, atenolol, 
atrazine, carbamazepine, diclofenac, progesterone, metoprolol, dilantin, DEET, 
pentoxifylline, oxybenzone, caffeine, iopromide, erythromycin, fluoxetine, trimethoprim, 
propranolol, sulfamethoxazole, ibuprofen, naproxen, bisphenol-A, gemfibrozil, and triclosan) 
from WWTP  at 1 μg L-1concentration. A strong degradation for all ECs at an average value 
of 70% occurred due to the breakdown of conjugated double bonds. Triclosan showed faster 
degradation rate (95%) while erythromycin the lowest degradation rate (50%). The 
degradation of all ECs followed the pseudo first order kinetic model. Therefore a significant 
reduction of the discharge of ECs into the environment could be expected through the use of 
catalysis, ultrasound irradiation and solar energy. Recent investigations increasingly focus on 
these systems; however, commercial applications are still scarce. 
The comparative removal of ECs by different chemical based oxidation processes is 
shown in Figure 6, where the average removal of different categories of ECs by Fenton and 
UV photolysis processes was found less effective than other chemical oxidation processes. It 
is also clearly seen that ozonation, ozonation in presence of hydrogen peroxide and photo-
Fenton processes showed greater efficiency in the removal of a wide range of ECs. Other 
processes were found to have a mixed effect in the removal of ECs. The average removal 
efficiencies of EDCs followed the order: ozonation ≥ UV photocatalysis > photo-Fenton > 
UV photolysis/H2O2 > solar photo-Fenton > UV photolysis. On the removal of pesticides, 
UV photolysis/H2O2 and electro-Fenton processes showed very similar high average removal 
efficiencies. The order of the removal of pesticides can be written as electro-Fenton ≈ UV 





solar photo-Fenton. On the other hand, the average removal efficiencies of beta blockers can 
be written as ozonation/ H2O2 ≈ UV photolysis/ H2O2 ≈ photo-Fenton > electro-Fenton> 
ozonation > UV photocatalysis > UV photolysis > Fenton process. The average removal 
efficiencies of analgesic pharmaceuticals by different chemical oxidation methods can be 
written as UV photolysis/H2O2 ≈ ozonation/H2O2 = photo-Fenton > ozonation > 
photocatalysis ≈ solar photo–Fenton > UV photolysis > Fenton process. For antibiotics, their 
average removal efficiencies can be ranked as ozonation/H2O2 > UV photolysis/H2O2 > 
ozonation > Photo-Fenton ≈ electro-Fenton > solar photo-Fenton > UV photocatalysis > UV 
photolysis. This kind of relationships for pharmaceutical lipid regulators, anti-inflammatory 
and miscellaneous pharmaceuticals can be developed (Figure 6). Thus it can be concluded 
that chemical based oxidation processes possess excellent oxidation characteristics in the 
removal of a wide range of ECs, although they involve comparatively high costs associated 
with the maintenance and operation, power consumption and different by-products in 
solution. The by-products can create problems due to their potential toxicity which can 
further increase the cost of the processes. 
 
4. Progress and challenges in hybrid systems 
The conventional wastewater treatment processes are not adequate for the effective removal 
of many ECs. A variety of hybrid treatment technologies are reported in the literature and 
during the last few years significant improvements have been achieved in their application in 
wastewater treatment, to prevent the release of ECs into the aquatic environment via effluent 
discharge. Most of the hybrid systems consist of biological based treatment system followed 
by some physical or chemical treatment systems. Chemical oxidation based treatment such as 
ozonation is the most widely used process to combine with biological process. Some 





MBR-reverse osmosis/ultrafiltration/microfiltration/ozonation, filtration and activated sludge 
followed by ultrafiltration. Microfiltration and ultrafiltration are increasingly being 
considered as alternatives to granular media filtration [174]. 
The remediation of 31 target ECs such as EDCs, pesticides and beta blockers by 
hybrid systems is represented in Table 6. Some EDCs such as E1, E2, EE2, E3, 17β-estradiol 
17-acetate, bisphenol A, 4-n-nonylphenol and 4-tert-butylphenol can be better removed by up 
to 99% through the combined use of MBR and some physical treatment technologies such as 
reverse osmosis, ultrafiltration or nanofiltration at concentrations up to 5 µg L-1. Combination 
of flocculation, activated sludge and ultrafiltration can also be employed but removal 
efficiencies of EDCs were low in some cases. This kind of combination can be more cost 
effective than MBR based hybrid systems. In term of removal of high influent concentrations 
of EDCs, MBR based hybrid system can become more effective and should be employed. 
The general trend for EDCs removal can be written as hybrid MBR with reverse osmosis or 
nanofiltration or ultrafiltration > flocculation–activated sludge–ultrafiltration > constructed 
wetland. 
A combination of flocculation, activated sludge and ultrafiltration was found less 
effective in the removal of pesticides such as 2,4-D and triclosan. Ozonation followed by 
biological activated carbon hybrid process is better than other processes such as MBR based 
hybrid systems (MBR-reverse osmosis/nanofiltration/ultrafiltration) for the removal of 
pesticides from WWTP or synthetic wastewater. For example, atrazine, 2,4-D, diazinon, 
diuron, metolochlor, praziquantel and triclopyr can be effectively removed using ozonation 
followed by biological activated carbon hybrid system. On the other hand, MBR based hybrid 
systems were found to be less effective for the removal of fenoprop and pentachlorophenol 
from synthetic wastewater. Triclosan was found to be well removed by MBR based hybrid 





ozonation-biological activated carbon > flocculation–activated sludge–ultrafiltration > 
constructed wetland > MBR plus reverse osmosis or nanofiltration or ultrafiltration.  
Hybrid treatment technologies such as MBR-reverse osmosis and ozonation– 
biological activated carbon were applied for the removal of atenolol, metoprolol and 
propranolol beta blockers, and both hybrid systems were found to achieve high removal 
efficiencies of over 99%. Ozonation followed by biological activated carbon system was 
slightly better than MBR-reverse osmosis for the removal of those beta blockers. On the other 
hand, sotalol, salbutamol, and salicylic acid beta blockers were found highly degraded in 
MBR-reverse osmosis hybrid system. Some of beta blockers such as butylated 
hydroxyanisole, butylated hydroxytoluene, DEHP, galaxolide, methyl dihydrojasmonate and 
tonalide showed low removal efficiencies during treatment using SFCW and HFCW (Table 
6). In some cases such as on the removal of salicylic acid and DEHP, activated sludge based 
hybrid system was found more effective than constructed wetland based hybrid systems. The 
general trend for the removal of beta blockers is ozonation–biological activated carbon > 
MBR with reverse osmosis or nanofiltration or ultrafiltration > flocculation–activated 
sludge–ultrafiltration > constructed wetland. 
Overall, on the removal of pharmaceuticals, the most widely employed hybrid 
systems are MBR-reverse osmosis, ozonation–MBR, activated sludge–gamma radiation, and 
ozonation–ultrasound. Ozonation followed by biological activated carbon hybrid system can 
successfully remove 94% to more than 99% of analgesics pharmaceuticals such as 
carbamazepine, codeine, diclofenac, ibuprofen, naproxen, paracetamol and tramadol (Figure 
7a, Table S6). Activated sludge followed by gamma radiation was found to be highly 
efficient for the removal of carbamazepine, diclosan and ibuprofen. Combined application of 
ultrafiltration, activated carbon and ultrasound hybrid system showed excellent performance 





effect of adsorption onto activated carbon and ultrasonic irradiation [177]. Other hybrid 
systems such as ozonation-ultrasound and MBR-reverse osmosis presented mixed removal 
efficiencies. Although some analgesics such as carbamazepine, diclofenac, metronidazole and 
primidone were degraded less efficiently in both types of hybrid systems, other analgesics 
such as codeine and ibuprofen can be completed removed. Flocculation followed by activated 
sludge and ultrafiltration can remove some analgesic pharmaceuticals and removal 
efficiencies were not so high like other hybrid systems such as ozonation-biological activated 
carbon or ozonation-gamma radiation, but this system is sometimes better than MBR based 
nanofiltration or ultrafiltration. As shown in Figure 7b, ozonation followed by gamma 
radiation hybrid system was found to be the best process for the removal of pain relievers, 
lipid regulators and diuretics. Ozonation–biological activated carbon hybrid system was 
found good for the removal of indomethacin, ketoprofen, gemfibrazil and furosemide but not 
for the removal of atorvastatin. Activated sludge followed by gamma radiation can remove 
100% of ketoprofen, mefanamic acid and clofibric acid. The same recommendation can be 
made for the hybrid flocculation–activated sludge-ultrafiltration process as made earlier. 
Thus on the removal of pharmaceutical analgesics, pain relievers, lipid regulators and 
diretics, ozonation-ultrasound and ozonation-biological activated carbon hybrid systems can 
be better employed than MBR based reverse osmosis/nanofiltration/ultrafiltration hybrid 
systems except for gemfibrozil removal (Figure 7). The general tread for  the removal of 
analgesics, lipid regulators and pain relievers by hybrid systems can be written as ozonation-
ultrasound ≥ ozonation-biological activated carbon > activated-gamma radiation > 
flocculation-activated sludge > MBR with reverse osmosis or ultrafiltration.  
The removal of antibiotics and other pharmaceuticals is represented in Table 7, which 
shows that MBR–reverse osmosis can successfully remove more than 99% of azithromycin, 





famotidine, ranitidine and clopidogrel. Ozonation followed by biological activated carbon 
hybrid system can be well applied in the removal of a wide range of ECs such as 
erythromycin, licomycin, roxithromycin, trimethoprim, caffeine, citalopram, doxylamine, 
phenytoin, risperidone, sertraline, hydrochlorothiazole and perindopril. But this hybrid 
system was found less effective in the removal of chloramphenicol, sulfamethaxazole, 
tylosin, dapsone and perindopril. The combined application of ultrafiltration, activated carbon 
and ultrasound was found highly effective in the removal of antibiotic amoxicillin even at 10 
mg L-1 level [177]. Ozonation followed by ultrafiltration hybrid system could remove up to 
100% of pharmaceuticals such as clarithromycin, clindamycin, sulfamethazine, 4-
aminoantipyrine, enalapril and norbenzoylecgonine, but was found less effective in the 
removal of licomycin, ofloxacin, venlafaxine and irbesartan (Table 7). Thus on the removal 
of antibiotics and miscellaneous pharmaceuticals hybrid systems followed the order of MBR-
reverse osmosis ≥ ozonation-biological activated carbon > ozonation-ultrafiltration. 
In summary, MBR based reverse osmosis/nanofiltration/ultrafiltration has been found 
highly efficient in the removal of a wide range of ECs such as EDCs, antibiotics and other 
pharmaceuticals. Other issues such as process cost, membrane fouling and energy demand 
need to be considered in designing such hybrid systems. Ozonation followed by biological 
activated carbon was found to more effective in the removal of pesticides, beta blockers, pain 
relievers, lipid regulators, analgesics, antibiotics and miscellaneous pharmaceuticals. But this 
process still suffers from lower efficiencies for some ECs. Ozonation followed by ultrasound 
hybrid system is a recent development in the removal of ECs, but this process may involve 
high costs and lower efficiencies in the removal of some ECs. In terms of cost, activated 
sludge based hybrid systems (activated sludge-ultrafiltration, activated sludge-gamma 
radiation) can also be a good alternative but need to consider the high retention time and 





the removal of many ECs. Data on the removal of PCPs and surfactants by hybrid systems 
are scarce. In future, some AOPs based treatment processes such as photolysis in the presence 
of hydrogen peroxide and photo-Fenton processes can be carefully integrated with the 
conventional processes.  
  
5. Future perspectives 
Different ECs can be effectively removed through different biological and chemical based 
methods but there are still deficiencies in the complete removal of ECs from wastewater. 
Some further research areas are suggested as follows: 
 There is a lack of detailed information on the degradation mechanisms involved, 
influence of operational variables on ECs removal, reaction kinetics and reactor design for 
optimum performance. 
 Integration of existing treatment systems with nanoscale science and engineering. 
 Challenges associated with wastewater sample preparations, analytical techniques and 
validation protocols for the reliable analysis of ECs in complex environmental samples. 
 Removal performance of different WWTP processes at various operational conditions 
should be re-evaluated with suitable sampling protocols. 
 Use of solar irradiation should be explored as an alternative AOP approach for 
reducing the costs of large scale commercial applications. 
 Hybrid technologies based on combined chemical and biological treatment processes, 
e.g. UV photolysis in the presence of H2O2 followed by MBR or biological activated carbon, 
ozonation in presence of H2O2 followed by MBR or biological activated carbon, photo-





 Combination of physical processes such as gamma radiation and ultrasound with 
adsorption on activated carbon or similar adsorbents (e.g. biochar) can also be integrated with 
the current wastewater treatment systems.  
 Ferrate process is a relatively green process and should be more extensively 
researched for industrial-scale applications.  
 New knowledge in genetic engineering should be introduced to select and amplify the 
most effective microbes for ECs degradation, which will reduce hydraulic retention time and 
save capital cost in reactor design.  
 The robustness and feasibility of full-scale chemical oxidation processes need to be 
extensively investigated to ensure ECs removal efficiencies and minimise toxic by-products. 
 
6. Conclusions 
Different biological processes were found to enhance the removal efficiency of different 
classes of ECs. For example, conventional activated sludge process has shown better removal 
efficiencies for surfactants, EDCs and PCPs than trickling filter and biofilm reactors, 
nitrification and denitrification processes. Biological activated carbon process has been 
reported with enhanced efficiencies in the removal of pesticides, analgesics and antibiotics. 
MBR process has been found to be highly effective in the removal of EDCs, PCPs and beta 
blockers than constructed wetland. Novel microalgae based technology has the highest 
efficiency in the removal of many categories of ECs especially pharmaceuticals and PCPs, 
although no data were reported on their removal of beta blockers, antibiotics and surfactants. 
On the other hand, chemical oxidation methods such as ozonation/H2O2, UV 
photolysis/H2O2 and photo-Fenton processes have been found to be the best processes for the 
removal of pesticides, beta blockers and pharmaceuticals. Ozonation and UV photocatalysis 





to be the least effective among all types of conventional and AOPs treatment technologies. 
The removal of surfactants and PCPs has not yet been well studied by chemical processes.  
Finally, hybrid systems such as MBR followed by reverse osmosis, nanofiltration or 
ultrafiltration are better for the removal of EDCs and pharmaceuticals, but less effective in 
the removal of pesticides. Ozonation followed by biological activated carbon hybrid system 
has been observed to be effective in the removal of pesticides, beta blockers and 
pharmaceuticals. Ozonation followed by ultrasound hybrid system can remove up to 100% of 
certain pharmaceuticals such as salicylic acid, ibuprofen, naproxen, acetaminophen, 
cocaethylene, benzoylecgonine, enalapril, norbenzoylecgonine, ketoprofen, atorvastatin, 
bezafibrate, clindamycin, sulfamethazine and 4-aminoantipyrine. Other hybrid systems based 
on activated sludge followed by ultrafiltration or activated sludge followed by gamma 
radiation are cost effective for the removal of certain EDCs, pesticides and analgesic 
pharmaceuticals. Hybrid systems using ultrafiltration, activated carbon followed by 
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Fig. 1. ECs removal achieved by activated sludge process with corresponding reference after 
compound name. a = antidepressant, b = contrast agent, c = gastroesophageal, d = 
vasodilator, e = antineoplastic, f = diuretic. The concentrations are in mg L-1 for empty 
columns. 
Fig. 2. Comparative average removal efficiency of ECs with standard deviation (error bar) 
for wastewater treatment (activated sludge, biological activated carbon, microalgae, MBR 
and constructed wetlands) and for sludge treatment (aerobic and anaerobic). 
Fig. 3. ECs removal efficiencies achieved by ozonation process with corresponding reference 
after compound name. Concentrations are in mg L-1 for empty columns and in g L-1 for dark 
columns. 
Fig. 4. ECs removal efficiencies achieved by ozonation in the presence of H2O2 (Figure 4a) 
and UV in the presence of H2O2 (Fig. 4b), with corresponding reference after compound 
name. Concentrations are in mg L-1 for empty columns and in g L-1 for dark columns. 1 = 
corrosion inhibitor, 2 = pain reliever, 3 = contrast agent, 4 = anti-inflammatory. 
Fig. 5. ECs removal efficiencies achieved by photo-Fenton (Fig. 5a) and UV photocatalysis 
(UV/TiO2) (Fig. 5b), with corresponding reference after compound name. Concentrations are 
in mg L-1 for empty columns and in g L-1 for chloramphenicol. 1 = pesticide, 2 = corrosion 
inhibitor, 3 = contrast agent, 4 = antidepressant, 5 = anti-diabetic, 6 = gastroesophageal, 7 = 
lipid regulator, 8 = diuretic, 9 = beta blocker, 10 = pain reliever, 11 = NSAID, 12 = stimulant. 
Fig. 6. Comparative average removal efficiency of ECs with standard deviation (error bar) by 
different chemical treatment technologies. 
Fig. 7. Pharmaceuticals removal efficiencies achieved by hybrid systems with corresponding 
reference after compound name. Concentrations are in mg L-1 for dark columns. 1 = codeine, 





indomethacin, 8 = mefanamic acid, 9 = atorvastatin, 10 = bezafibrate, 11 = clofibric acid, 12 
= furosemide. 
